Thor K B, Roppolo J R, deGroat W C
J Urol. 1983 Jan;129(1):202-5. doi: 10.1016/s0022-5347(17)51984-9.
In chronic spinal cats 2 to 10 weeks after transection of the spinal cord at the lower thoracic level (T12-T13), the administration of naloxone, an opiate antagonist, (32-500 micrograms./kg. i.p.), stimulated micturition. The total quantity of urine released after administration of naloxone ranged from 10 to 70 per cent, (mean 39 per cent) of the initial bladder volume. The response to the drug occurred 5 to 10 minutes after injection and was characterized by repeated periodic expulsion of small quantities of urine (5 to 10 ml.) which coincided with a pattern of hind-limb movement which resembled walking behavior. The effects of naloxone persisted for about 1 hour. The motor activity following administration of naloxone was dependent upon activation of bladder afferents since it did not occur when the bladder was empty. Naloxone also facilitated the release of urine induced by stimulation of somatic afferents. With repeated administration of naloxone, tolerance developed which was evident for several days. These observations suggest that an endogenous opiate may have a tonic inhibitory role in regulation of micturition. Pharmacologic manipulation of this putative inhibitory mechanism may facilitate management of neurogenic bladder dysfunction.
在胸段脊髓下部(T12 - T13)横断脊髓2至10周后的慢性脊髓损伤猫中,注射阿片拮抗剂纳洛酮(32 - 500微克/千克,腹腔注射)可刺激排尿。注射纳洛酮后排出的尿液总量为初始膀胱容量的10%至70%(平均39%)。用药后5至10分钟出现对药物的反应,其特征是反复周期性排出少量尿液(5至10毫升),同时伴有类似于行走行为的后肢运动模式。纳洛酮的作用持续约1小时。注射纳洛酮后的运动活动依赖于膀胱传入神经的激活,因为膀胱排空时不会出现这种活动。纳洛酮还促进了躯体传入神经刺激诱导的尿液排出。反复注射纳洛酮会产生耐受性,这种耐受性可持续数天。这些观察结果表明,内源性阿片可能在排尿调节中具有紧张性抑制作用。对这种假定的抑制机制进行药理学操作可能有助于治疗神经源性膀胱功能障碍。